18th Conference on Retroviruses and Opportunistic Infections (CROI) 27 February-3 March 2011, Boston
Our final reports from this important conference are:
- Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110/ESTER trials
- DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells/mm3 could reduce unnecessary switching
- Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST
Unless mentioned otherwise, all references are to the Programme and Abstracts of the 18th Conference on Retroviruses and Opportunistic Infections, 28 February2 March 2011, Boston.
Webcasts are available at the following link: